← Back to headlines
Camp4 Therapeutics CSO Daniel Tardiff Sells $8,272 in Common Stock
Daniel Tardiff, the Chief Scientific Officer of Camp4 Therapeutics, has sold $8,272 worth of common stock.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Prediction Platform Kalshi Bans Former Congressman George Santos for Life
26m ago
U.S. Treasury Yields Surge as Fed Official Signals Support for Rate Hike
1h ago
Dell Stock Gains Investor Focus Ahead of September Earnings Report
1h ago
Sony and Warner Music Sue Anthropic Over AI Training Copyright Claims
1h ago